Cargando…
LRRC15 inhibits SARS-CoV-2 cellular entry in trans
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is mediated by the entry receptor angiotensin-converting enzyme 2 (ACE2). Although attachment factors and coreceptors facilitating entry are extensively studied, cellular entry factors inhibiting viral entry are largely unknown....
Autores principales: | Song, Jaewon, Chow, Ryan D., Peña-Hernández, Mario A., Zhang, Li, Loeb, Skylar A., So, Eui-Young, Liang, Olin D., Ren, Ping, Chen, Sidi, Wilen, Craig B., Lee, Sanghyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595563/ https://www.ncbi.nlm.nih.gov/pubmed/36228039 http://dx.doi.org/10.1371/journal.pbio.3001805 |
Ejemplares similares
-
LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans
por: Song, Jaewon, et al.
Publicado: (2021) -
Exploiting LRRC15 as a Novel Therapeutic Target in Cancer
por: Ray, Upasana, et al.
Publicado: (2022) -
Targeting LRRC15 Inhibits Metastatic Dissemination of Ovarian Cancer
por: Ray, Upasana, et al.
Publicado: (2022) -
LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications
por: Ben-Ami, Eytan, et al.
Publicado: (2020) -
LRRC15(+) myofibroblasts dictate the stromal setpoint to suppress tumour immunity
por: Krishnamurty, Akshay T., et al.
Publicado: (2022)